Pcep logo
Book 3: Maternal and Fetal Care
UNIT 11: NEONATAL ABSTINENCE SYNDROME (NEONATAL OPIOID WITHDRAWAL SYNDROME)

Select the one best answer to each question (unless otherwise instructed). Record your answers on the test.
Neonatal opioid withdrawal syndrome (NOWS), also known as neonatal abstinence syndrome (NAS), is a multisystem disorder caused by the abrupt discontinuation of chronic fetal exposure to substances used by the mother during pregnancy. Which of the following statements describes a sign or symptom shown to be specific for NAS/NOWS?
The risk, timing, and duration of NAS/NOWS depends on the type of substance used by the mother. Which of the following exposures is most likely to result in withdrawal signs and symptoms in the first 24 hours after birth
How long should a healthy term neonate who is at risk for NAS/NOWS be monitored in the hospital after birth?
Which of the following increases the risk and/or severity of developing NAS/NOWS in newborns exposed to in utero opioids?
While NAS is a clinical diagnosis, toxicological confirmation is necessary to be able to identify the exact type of substance used, as well as confirm and/or rule out expo­ sure to other licit and illicit substances. Which of the following statements regarding toxicology screening in the newborn is correct?
The Eat, Sleep, Console (ESC) approach was developed to assist in the monitoring and management of neonates with NAS. Which of the following statements regard­ ing ESC is incorrect?
The use of the ESC approach to manage newborns with NAS/NOWS is associated with an increased risk of hospital readmission for NAS symptoms .
Nonpharmacological interventions are the preferred first-line treatment for NAS/ NOWS and should be optimized prior to considerations of pharmacological treat­ ment. Which of the following statements regarding nonpharmacological manage­ ment approaches is incorrect?
Breastfeeding is contraindicated in neonates with NAS/NOWS
Establishing a safe care plan for neonates with NAS/NOWS is a federal mandate .